196 related articles for article (PubMed ID: 11462975)
1. Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.
Kim YC; Brown SG; Harden TK; Boyer JL; Dubyak G; King BF; Burnstock G; Jacobson KA
J Med Chem; 2001 Feb; 44(3):340-9. PubMed ID: 11462975
[TBL] [Abstract][Full Text] [Related]
2. A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors.
Jacobson KA; Kim YC; Wildman SS; Mohanram A; Harden TK; Boyer JL; King BF; Burnstock G
J Med Chem; 1998 Jun; 41(13):2201-6. PubMed ID: 9632352
[TBL] [Abstract][Full Text] [Related]
3. Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus.
Rodrigues RJ; Almeida T; Richardson PJ; Oliveira CR; Cunha RA
J Neurosci; 2005 Jul; 25(27):6286-95. PubMed ID: 16000618
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of pyridoxal phosphate derivatives with antagonist activity at the P2Y13 receptor.
Kim YC; Lee JS; Sak K; Marteau F; Mamedova L; Boeynaems JM; Jacobson KA
Biochem Pharmacol; 2005 Jul; 70(2):266-74. PubMed ID: 15913566
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cultured dorsal root ganglion neuron P2X receptors.
Grubb BD; Evans RJ
Eur J Neurosci; 1999 Jan; 11(1):149-54. PubMed ID: 9987019
[TBL] [Abstract][Full Text] [Related]
6. P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels.
Nicke A; Bäumert HG; Rettinger J; Eichele A; Lambrecht G; Mutschler E; Schmalzing G
EMBO J; 1998 Jun; 17(11):3016-28. PubMed ID: 9606184
[TBL] [Abstract][Full Text] [Related]
7. TNP-ATP, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: comparison with reference analgesics.
Honore P; Mikusa J; Bianchi B; McDonald H; Cartmell J; Faltynek C; Jarvis MF
Pain; 2002 Mar; 96(1-2):99-105. PubMed ID: 11932066
[TBL] [Abstract][Full Text] [Related]
8. Actions of a Series of PPADS Analogs at P2X
Brown SG; Kim YC; Kim SA; Jacobson KA; Burnstock G; King BF
Drug Dev Res; 2001 Aug; 53(4):281-291. PubMed ID: 27134334
[TBL] [Abstract][Full Text] [Related]
9. Lack of run-down of smooth muscle P2X receptor currents recorded with the amphotericin permeabilized patch technique, physiological and pharmacological characterization of the properties of mesenteric artery P2X receptor ion channels.
Lewis CJ; Evans RJ
Br J Pharmacol; 2000 Dec; 131(8):1659-66. PubMed ID: 11139444
[TBL] [Abstract][Full Text] [Related]
10. Cloning, tissue distribution and functional characterization of the chicken P2X1 receptor.
Soto F; Krause U; Borchardt K; Ruppelt A
FEBS Lett; 2003 Jan; 533(1-3):54-8. PubMed ID: 12505158
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the binding characteristics of recombinant P2X1 and P2X2 purinoceptors.
Michel AD; Lundström K; Buell GN; Surprenant A; Valera S; Humphrey PP
Br J Pharmacol; 1996 Aug; 118(7):1806-12. PubMed ID: 8842447
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.
Nandanan E; Camaioni E; Jang SY; Kim YC; Cristalli G; Herdewijn P; Secrist JA; Tiwari KN; Mohanram A; Harden TK; Boyer JL; Jacobson KA
J Med Chem; 1999 May; 42(9):1625-38. PubMed ID: 10229631
[TBL] [Abstract][Full Text] [Related]
13. Selective potentiation of homomeric P2X2 ionotropic ATP receptors by a fast non-genomic action of progesterone.
De Roo M; Boué-Grabot E; Schlichter R
Neuropharmacology; 2010 Mar; 58(3):569-77. PubMed ID: 20004677
[TBL] [Abstract][Full Text] [Related]
14. Distribution of P2X1, P2X2, and P2X3 receptor subunits in rat primary afferents: relation to population markers and specific cell types.
Petruska JC; Cooper BY; Gu JG; Rau KK; Johnson RD
J Chem Neuroanat; 2000 Nov; 20(2):141-62. PubMed ID: 11118807
[TBL] [Abstract][Full Text] [Related]
15. The purinergic component of human vas deferens contraction.
Banks FC; Knight GE; Calvert RC; Thompson CS; Morgan RJ; Burnstock G
Fertil Steril; 2006 Apr; 85(4):932-9. PubMed ID: 16580377
[TBL] [Abstract][Full Text] [Related]
16. Acyclic and cyclopropyl analogues of adenosine bisphosphate antagonists of the P2Y1 receptor: structure-activity relationships and receptor docking.
Kim HS; Barak D; Harden TK; Boyer JL; Jacobson KA
J Med Chem; 2001 Sep; 44(19):3092-108. PubMed ID: 11543678
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Structure-Activity Relationships of Pyridoxal-6-arylazo-5'-phosphate and Phosphonate Derivatives as P2 Receptor Antagonists.
Kim YC; Camaioni E; Ziganshin AU; Ji XD; King BF; Wildman SS; Rychkov A; Yoburn J; Kim H; Mohanram A; Harden TK; Boyer JL; Burnstock G; Jacobson KA
Drug Dev Res; 1998 Oct; 45(2):52-66. PubMed ID: 22922976
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of diadenosine polyphosphates for rat P2X receptor subunits.
Wildman SS; Brown SG; King BF; Burnstock G
Eur J Pharmacol; 1999 Feb; 367(1):119-23. PubMed ID: 10082274
[TBL] [Abstract][Full Text] [Related]
19. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
[TBL] [Abstract][Full Text] [Related]
20. Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.
Obrecht AS; Urban N; Schaefer M; Röse A; Kless A; Meents JE; Lampert A; Abdelrahman A; Müller CE; Schmalzing G; Hausmann R
Neuropharmacology; 2019 Nov; 158():107749. PubMed ID: 31461640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
